April 2, 2022 Comments Off on New patent for Nalpropion drug CONTRAVE Posted in: Patent Added Annual Drug Patent Expirations for CONTRAVE Contrave is a drug marketed by Nalpropion and is included in one NDA. It is available from three suppliers. There are eighteen patents protecting…
The post New patent for Nalpropion drug CONTRAVE appeared fir…
April 2, 2022 Comments Off on New patent for Sarepta Theraps drug AMONDYS 45 Posted in: Patent Added Annual Drug Patent Expirations for AMONDYS+45 Amondys 45 is a drug marketed by Sarepta Theraps Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent for Sarepta Theraps drug AMONDYS 45 appeared first on DrugP…